- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT07745192
Effects of a Lateral Position With Hip Flexion and Femoral Internal Rotation During the Second Stage of Labor in Nulliparous Women Receiving Epidural Analgesia
30. juli 2026 oppdatert av: Second Affiliated Hospital of Wenzhou Medical University
This randomized clinical study evaluated the effects of a lateral position with hip flexion and femoral internal rotation during the second stage of labor in nulliparous women receiving epidural labor analgesia.
Participants were assigned to either an observation group using the modified lateral position or a control group using the conventional lateral position.
The study compared second-stage labor duration, additional obstetric interventions, maternal outcomes, perineal outcomes, and neonatal outcomes between the two groups.
Studieoversikt
Status
Fullført
Studietype
Intervensjonell
Registrering (Faktiske)
230
Fase
- Ikke aktuelt
Kontakter og plasseringer
Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.
Studiesteder
-
-
Zhejiang
-
Wenzhou, Zhejiang, Kina, 325000
- Nanpu Branch of The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University
-
-
Deltakelseskriterier
Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
- Voksen
Tar imot friske frivillige
Nei
Beskrivelse
Inclusion Criteria:
- Nulliparous women.
- Age 22 to 34 years.
- Singleton pregnancy.
- Cephalic presentation confirmed by ultrasonography after 37 weeks of gestation.
- Gestational age of 37 to 41 weeks.
- Estimated fetal weight of 2,500 to 3,500 g.
- No birth-canal abnormalities on vaginal examination.
- Effective epidural labor analgesia during the first stage of labor.
- Sufficient cognitive capacity to understand and cooperate with the study procedures.
- Ability and willingness to provide written informed consent.
Exclusion Criteria:
- Organic heart, liver, or kidney disease.
- Prenatal indication for cesarean delivery.
- Pubic symphysis separation.
- Lower-limb disease or impaired mobility.
- Precipitous labor.
- Second stage of labor lasting less than 30 minutes.
- Severe mental illness.
- Fetal malformation.
- Withdrawal from the study.
Studieplan
Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Støttende omsorg
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Ingen (Open Label)
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Eksperimentell: Modified Lateral Position Group
Participants in this group adopted a lateral position with hip flexion and femoral internal rotation during the second stage of labor under midwife assistance.
|
Participants adopted a modified lateral position during the second stage of labor.
The position involved lateral positioning facing the side opposite to the fetal back, hip flexion, knee flexion, and 30°-40° femoral internal rotation with midwife assistance.
The position was used during uterine contractions with guided bearing-down efforts and was alternated with a semi-recumbent position according to the study protocol.
|
|
Aktiv komparator: Conventional Lateral Position Group
Participants in this group adopted the conventional lateral position during the second stage of labor under routine intrapartum care and midwife
|
Participants adopted the conventional lateral position during the second stage of labor under routine intrapartum care and midwife assistance.
During uterine contractions, participants performed bearing-down efforts in the lateral position, followed by intervals of rest and semi-recumbent positioning according to the study protocol.
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Duration of the Second Stage of Labor
Tidsramme: From full cervical dilatation to delivery of the neonate
|
From full cervical dilatation to delivery of the neonate
|
|
|
Additional Obstetric Interventions During the Second Stage of Labor
Tidsramme: During the second stage of labor
|
Additional obstetric interventions during the second stage of labor, classified as none, forceps-assisted vaginal birth, cesarean delivery during the second stage, vaginal birth after manual fetal-head rotation, or vaginal birth with episiotomy as the principal intervention.
|
During the second stage of labor
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Duration of the First Stage of Labor
Tidsramme: From onset of regular uterine contractions to full cervical dilatation
|
Duration of the first stage of labor, measured in minutes.
|
From onset of regular uterine contractions to full cervical dilatation
|
|
Duration of the Third Stage of Labor
Tidsramme: From delivery of the neonate to delivery of the placenta
|
Duration of the third stage of labor, measured in minutes.
|
From delivery of the neonate to delivery of the placenta
|
|
Postpartum Blood Loss
Tidsramme: Within 2 hours after delivery
|
Postpartum blood loss, measured in milliliters.
|
Within 2 hours after delivery
|
|
Perineal Outcomes
Tidsramme: At delivery
|
Perineal outcomes classified as intact perineum, episiotomy, first-degree perineal laceration, or second-degree or higher perineal laceration.
|
At delivery
|
Samarbeidspartnere og etterforskere
Det er her du vil finne personer og organisasjoner som er involvert i denne studien.
Studierekorddatoer
Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.
Studer hoveddatoer
Studiestart (Faktiske)
1. februar 2025
Primær fullføring (Faktiske)
30. desember 2025
Studiet fullført (Faktiske)
30. desember 2025
Datoer for studieregistrering
Først innsendt
30. juli 2026
Først innsendt som oppfylte QC-kriteriene
30. juli 2026
Først lagt ut (Faktiske)
4. august 2026
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
4. august 2026
Siste oppdatering sendt inn som oppfylte QC-kriteriene
30. juli 2026
Sist bekreftet
1. juli 2026
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Andre studie-ID-numre
- SAHoWMU-CR2024-07-118
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
UBESLUTTE
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Nei
Studerer et amerikansk FDA-regulert enhetsprodukt
Nei
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .